| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |